Category Archives: News

Pfizer rolls out Retacrit, a biosim to Amgen and J&J anemia blockbusters, at a big discount

After experiencing slow uptake for its first biosim launch, Pfizer isn’t giving up on the budding field. On Wednesday, the drugmaker introduced its third biosim, and second in two months, launching anemia treatment Retacrit at a significant discount to Amgen’s Epogen and Johnson & Johnson’s Procrit. Pfizer started shipping Retacrit to wholesalers on Monday at… Read More »

CMS approves Michigan Medicaid drug value-based payment plan

Dive Brief: CMS Administrator Seema Verma announced Wednesday the agency has approved a Michigan plan allowing its state Medicaid program to work with drugmakers to allow value-based payment arrangements in an effort to “modernize payment policies.” The proposal is the second to receive a green light, following approval of a similar Oklahoma plan in June.  … Read More »

Is Big Data the New Moneyball?

Organizations on the leading edge are also strategically leveraging information technology and data analytics as a key facilitator to continuous performance improvement, particularly on the clinical side

Why Teenagers Mix Drinking and Sex

Adults should talk with teenagers about drinking. And we should talk with teenagers about sex. But in addition to taking up each of these topics separately, we should also address the fact that adolescents are more likely than adults to combine the two. Common sense suggests, and research confirms, that intoxicated sex can be a… Read More »

BitSight Recognised as a Leader in Cybersecurity Rating Solutions report by Independent Research Firm

London, 14th November 2018 — BitSight, the Standard in Security Ratings, today announced that it has been named a Leader in The Forrester New Wave™: Cybersecurity Risk Rating Solutions, Q4 2018 evaluation. BitSight believes its inclusion and positioning in this report further affirms BitSight’s visionary and strategic approach as well as its dominant market presence… Read More »